Archive · 1 Oct 2025
Virupaksha Organics to Launch IPO to Raise Funds
Virupaksha Organics, a pharmaceutical company, plans to raise money by selling shares to the public through an IPO.
They aim to collect around Rs 740 crore.
The money will be used to expand their manufacturing capabilities, pay off debts, and for other business activities.
Virupaksha makes active pharmaceutical ingredients (APIs) and intermediates, with a wide range of products and customers in many countries.
The company has manufacturing units in Telangana and Karnataka.
The company had Rs 811 crore in revenue and Rs 78 crore profit in FY25.
The Indian market for these products is expected to grow.
Virupaksha Organics filed for an IPO to raise Rs 740 crore.
The IPO is a fresh issue of equity shares.
Funds will be used for capacity expansion, debt payment, and general purposes.
The company makes APIs and intermediates and has 54 products.
Virupaksha operates six manufacturing units across Telangana and Karnataka.
- Who
- Virupaksha Organics
- What
- Filed for an IPO to raise Rs 740 crore
- When
- Filed preliminary papers, as of the report
- Where
- Hyderabad, Telangana and Humnabad, Karnataka
- Why
- To fund capacity expansion, pay debt, and for general corporate purposes
- Company
- Virupaksha Organics
- Industry
- Pharmaceuticals
- IPO Amount
- Rs 740 crore
- Use of Funds
- Capacity expansion, debt payment, general corporate purposes
- Products
- APIs and intermediates
- FY25 Revenue
- Rs 811 crore
- FY25 Profit
- Rs 78 crore